Northern Trust’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.74M | Buy |
|
|||||
|
2023
Q4 | $1.57M | Buy |
|
|||||
|
2023
Q3 | $1.42M | Sell |
|
|||||
|
2023
Q2 | $1.43M | Buy |
|
|||||
|
2023
Q1 | $343K | Buy |
|
|||||
|
2022
Q4 | $296K | Buy |
|
|||||
|
2022
Q3 | $90K | Buy |
|
|||||
|
2022
Q2 | $142K | Sell |
|
|||||
|
2022
Q1 | $159K | Sell |
|
|||||
|
2021
Q4 | $98K | Hold |
|
|||||
|
2021
Q3 | $121K | Sell |
|
|||||
|
2021
Q2 | $203K | Sell |
|
|||||
|
2021
Q1 | $228K | Buy |
|
|||||
|
2020
Q4 | $247K | Sell |
|
|||||
|
2020
Q3 | $146K | Sell |
|
|||||
|
2020
Q2 | $139K | Sell |
|
|||||
|
2020
Q1 | $171K | Sell |
|
|||||
|
2019
Q4 | $251K | Sell |
|
|||||
|
2019
Q3 | $360K | Sell |
|
|||||
|
2019
Q2 | $491K | Buy |
|
|||||
|
2019
Q1 | $563K | Buy |
|
|||||
|
2018
Q4 | $233K | Buy |
|
|||||
|
2018
Q3 | $267K | Buy |
|
|||||
|
2018
Q2 | $243K | Sell |
|
|||||
|
2018
Q1 | $1.28M | Buy |
|
|||||
|
2017
Q4 | $1.53M | Buy |
|
|||||
|
2017
Q3 | $2.15M | Buy |
|
|||||
|
2017
Q2 | $1.8M | Buy |
|
|||||
|
2017
Q1 | $4.37M | Sell |
|
|||||
|
2016
Q4 | $5.86M | Buy |
|
|||||
|
2016
Q3 | $8.72M | Sell |
|
|||||
|
2016
Q2 | $7.47M | Buy |
|
|||||
|
2016
Q1 | $11.2M | Buy |
|
|||||
|
2015
Q4 | $10.3M | Buy |
|
|||||
|
2015
Q3 | $10.5M | Sell |
|
|||||
|
2015
Q2 | $15.2M | Buy |
|
|||||
|
2015
Q1 | $13.3M | Buy |
|
|||||
|
2014
Q4 | $12.3M | Sell |
|
|||||
|
2014
Q3 | $9.92M | Sell |
|
|||||
|
2014
Q2 | $8.27M | Sell |
|
|||||
|
2014
Q1 | $6.35M | Sell |
|
|||||
|
2013
Q4 | $7.2M | Buy |
|
|||||
|
2013
Q3 | $4.98M | Buy |
|
|||||
|
2013
Q2 | $3.36M | Buy |
|